Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 13 studies | 53% ± 25% | |
| smooth muscle cell | 7 studies | 29% ± 17% | |
| glutamatergic neuron | 5 studies | 24% ± 13% | |
| adipocyte | 5 studies | 30% ± 7% | |
| GABAergic neuron | 5 studies | 28% ± 18% | |
| myofibroblast cell | 4 studies | 38% ± 21% | |
| pericyte | 3 studies | 23% ± 8% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 32% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 96% | 1719.42 | 236 / 245 | 93% | 13.38 | 467 / 502 |
| brain | 74% | 1154.85 | 1947 / 2642 | 72% | 17.70 | 506 / 705 |
| bladder | 100% | 2737.71 | 21 / 21 | 22% | 1.68 | 112 / 504 |
| esophagus | 81% | 3562.00 | 1173 / 1445 | 31% | 2.17 | 56 / 183 |
| breast | 70% | 640.02 | 321 / 459 | 18% | 0.69 | 203 / 1118 |
| uterus | 64% | 904.21 | 109 / 170 | 24% | 1.56 | 109 / 459 |
| blood vessel | 81% | 1640.08 | 1080 / 1335 | 0% | 0 | 0 / 0 |
| skin | 45% | 258.49 | 814 / 1809 | 29% | 2.17 | 138 / 472 |
| intestine | 57% | 354.16 | 547 / 966 | 11% | 0.46 | 58 / 527 |
| lung | 37% | 195.23 | 215 / 578 | 16% | 0.46 | 189 / 1155 |
| stomach | 39% | 633.67 | 139 / 359 | 10% | 0.31 | 29 / 286 |
| eye | 0% | 0 | 0 / 0 | 43% | 3.14 | 34 / 80 |
| thymus | 0% | 0.61 | 1 / 653 | 29% | 0.79 | 173 / 605 |
| adipose | 25% | 134.89 | 301 / 1204 | 0% | 0 | 0 / 0 |
| kidney | 13% | 124.63 | 12 / 89 | 8% | 0.20 | 76 / 901 |
| adrenal gland | 0% | 0 | 0 / 258 | 17% | 2.73 | 38 / 230 |
| ovary | 3% | 11.50 | 5 / 180 | 13% | 1.84 | 57 / 430 |
| pancreas | 0% | 0 | 0 / 328 | 6% | 0.17 | 11 / 178 |
| tonsil | 0% | 0 | 0 / 0 | 4% | 0.20 | 2 / 45 |
| muscle | 2% | 6.93 | 13 / 803 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 1% | 0.06 | 3 / 406 |
| heart | 0% | 0.64 | 1 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0008284 | Biological process | positive regulation of cell population proliferation |
| GO_0030198 | Biological process | extracellular matrix organization |
| GO_0008283 | Biological process | cell population proliferation |
| GO_0008150 | Biological process | biological_process |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0031012 | Cellular component | extracellular matrix |
| GO_0043395 | Molecular function | heparan sulfate proteoglycan binding |
| GO_0030305 | Molecular function | heparanase activity |
| Gene name | HPSE2 |
| Protein name | Mutant heparanase 2 Heparanase 2 Heparanase 2 (inactive) Inactive heparanase-2 (Hpa2) |
| Synonyms | HPA2 |
| Description | FUNCTION: Binds heparin and heparan sulfate with high affinity, but lacks heparanase activity. Inhibits HPSE, possibly by competing for its substrates (in vitro). . |
| Accessions | Q2M1H9 ENST00000370549.5 [Q8WWQ2-3] ENST00000370546.5 [Q8WWQ2-2] ENST00000370552.8 [Q8WWQ2-1] ENST00000404542.5 F8S1G9 Q8WWQ2 A0A0A0MSB9 ENST00000628193.2 [Q8WWQ2-4] |
